Qianying Ouyang
- Topics
- RNA modifications and cancer (3 papers)CRISPR and Genetic Engineering (3 papers)Peptidase Inhibition and Analysis (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Qianying Ouyang
11 papers receiving 244 citations
Peers
Comparison fields: 5 of 53
- Molecular Biology 137
- Cancer Research 77
- Oncology 68
- Immunology 32
- Radiology, Nuclear Medicine and Imaging 30
Countries citing papers authored by Qianying Ouyang
This map shows the geographic impact of Qianying Ouyang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianying Ouyang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianying Ouyang more than expected).
Fields of papers citing papers by Qianying Ouyang
This network shows the impact of papers produced by Qianying Ouyang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianying Ouyang. The network helps show where Qianying Ouyang may publish in the future.
Co-authorship network of co-authors of Qianying Ouyang
This figure shows the co-authorship network connecting the top 25 collaborators of Qianying Ouyang. A scholar is included among the top collaborators of Qianying Ouyang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qianying Ouyang. Qianying Ouyang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 17 | |
| 4 | 60 | |
| 5 | 13 | |
| 6 | 7 | |
| 7 | 34 | |
| 8 | 33 | |
| 9 | Loss of ZNF587B and SULF1 contributed to cisplatin resistance in ovarian cancer cell lines based on Genome-scale CRISPR/Cas9 screening. | 26 |
| 10 | 18 | |
| 11 | 2 | |
| 12 | 30 |
About Qianying Ouyang
Qianying Ouyang is a scholar working on Oncology, Cancer Research and Nutrition and Dietetics, having authored 12 papers that have together received 245 indexed citations. Recurring topics across this work include RNA modifications and cancer (3 papers), CRISPR and Genetic Engineering (3 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Cancer Research (77 citations), Reproductive Medicine (28 citations) and Oncology (68 citations). Qianying Ouyang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Feiyue Zeng, Yan Zhan, Yingzi Liu, Ji‐Ye Yin, Jiajia Cui, Ke Liu, Dong‐Hua Yang, Xiangping Li, Xi Li and Keqiang Zhang. Their work appears in journals such as Molecular Cancer, Biomedicine & Pharmacotherapy and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.